← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 22, 2024Last known activity
Nov 22, 2024
Timeline
1990s
- Nov 26, 1997
mangafodipir trisodium— NDA Organization
- Nov 26, 1997
mangafodipir trisodium— NDA Secondary Org
2010s
- Jun 1, 2015
IC Targets— Founded
Drugs by trial phase (2 distinct, 1 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (1)
Recent trials (1)
- NCT06731738Lead sponsorPhase 2Nov 22, 2024
Details
- Founded
- Oslo, NO Jun 1, 2015
- Last known activity
- Nov 22, 2024